Zoekresultaten - 10 results

Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework.

efficiency and PCR inhibition. 1300 VALGENT-2 study samples (from women aged 20-60 attending the Scottish cervical cancer screening program) were tested with the index assay and the GP5 +/6+ PCR enzyme ...

Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia

cancer Cervical cancer prevention EVALUATION Health economics Modelling Simulation Abstract: OBJECTIVE Australia’s HPV vaccination and HPV-based cervical screening programs are changing the landscape in ...

Cervical morbidity in Alsace, France: results from a regional organized cervical cancer screening program.

program of cervical cancer screening was introduced in the Alsace region, France. Women aged 25-65 years were proposed to have one Pap smear every 3 years. The objective was to assess cervical morbidity in ...

Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.

the cobas 4800 HPV test (cobas). The panel comprises 1,300 stored samples that were obtained from women 25 to 64 years old who participated in the Slovenian cancer screening program, enriched with 300 ...

Barriers to and facilitators of compliance with clinic-based cervical cancer screening: population-based cohort study of women aged 23-60 years.

METHODS: 1510 women attending the clinic-based cervical cancer screening program in Stockholm, Sweden were included. Data on sociodemographic characteristics, time and travel costs and other direct ...

Offering Self-Sampling Kits for HPV Testing to Reach Women Who Do Not Attend in the Regular Cervical Cancer Screening Program.

cervical cancer screening, with cytology triage for those with a positive HPV test. The new Dutch program includes sending self-sampling devices to women who do not respond to an invitation to have ...

Cervical cancer screening program and Human Papillomavirus (HPV) testing, part II: Update on HPV primary screening.

screening cervical cancer HPV Abstract: Key Findings   HPV testing is more sensitive for precancerous lesions CIN2 and CIN3 than cytology. The downside is that the transversal specificity is lower. The ...

IPAAC Rapport WP4: Cancer control policy interview survey

screening, the extent of implementation of screening programs varies widely among EU Member States. The most often reported challenges concern test selection, non-appropriate governance and/or legal frameworks ...

QR code

QR code for this page URL